Prognostic value of myocardial perfusion scintigraphy for patients suspected of and diagnosed with coronary artery disease

BACKGROUND: The prognostic value of myocardial perfusionscintigraphy (MPS) continues to attract interest and provoke discussions.This study was an attempt to investigate the methods.Objective: Determination of the prognostic value of MPSfor patients suspected of and diagnosed with coronary arterydis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nuclear medicine review. Central & Eastern Europe 2012-01, Vol.15 (1), p.14-21
Hauptverfasser: Zorga, Piotr, Birkenfeld, Bożena, Listewnik, Maria Henryka, Piwowarska-Bilska, Hanna
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 21
container_issue 1
container_start_page 14
container_title Nuclear medicine review. Central & Eastern Europe
container_volume 15
creator Zorga, Piotr
Birkenfeld, Bożena
Listewnik, Maria Henryka
Piwowarska-Bilska, Hanna
description BACKGROUND: The prognostic value of myocardial perfusionscintigraphy (MPS) continues to attract interest and provoke discussions.This study was an attempt to investigate the methods.Objective: Determination of the prognostic value of MPSfor patients suspected of and diagnosed with coronary arterydisease (CAD).MATERIAL AND METHODS: The study group included 215patients, 134 males and 81 females, aged 21–66, mean age48. Tc-99m-MIBI myocardial perfusion scintigraphy was performedand information concerning the diagnosis, aim of theexamination, past coronary episodes, clinical condition, durationand type of complaints, concomitant diseases, test results,revascularisation procedures and pharmacological treatmentwas gathered. Further history of the patients was monitoredthroughout the observation period of 52 months on average.The patients were divided into the following two groups: GroupI — suspected coronary artery disease: 124 patients aged 21–65,59 males and 65 females; Group II — diagnosed coronary arterydisease: 91 patients aged 31–66, 75 males and 16 femalesdiagnosed with CAD, including 39 s/p myocardial infarct, 31s/p infarct and revascularisation, 21 s/p revascularisation. Theprobability of CAD was calculated using the Diamond methodfor the patients suspected of CAD. The obtained results wereexamined in a statistical analysis.RESULTS: Normal MPS results were obtained for 94/124 patientssuspected of CAD, 15/91 patients diagnosed with CAD,64/81 females and 45/134 males. In Group I, apart from pathologicalMPS results, reversible ischemia was determined in asmany as 27/30 patients, and only 17/91 patients in Group II. Nopatients with normal MPS results suffered major cardiac events,only one of them underwent revascularisation. Major cardiacevents occurred in the case of patients with pathological MPSresults: Group I — 2 myocardial infarcts and 2 cardiac deaths,Group II — 3 infarcts and 10 cardiac deaths. Minor cardiacevents, apart from one case, were also only observed in thecase of patients with pathological MPS results: Group I — 10revascularisations and one case of unstable CAD, Group II— 12 revascularisations and 7 cases of unstable CAD. Patientswith normal MPS results and stenosis in coronary angioraphysuffered no cardiac events. Cardiac events occur mostly in thegroup with a medium and high risk of CAD and in the case ofpatients diagnosed with CAD.CONCLUSIONS: 1. Normal MPS results for patients suspectedof or diagnosed with CAD: s/p infarct and/or CABG
doi_str_mv 10.5603/NMR.2012.0004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2464226139</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2464226139</sourcerecordid><originalsourceid>FETCH-LOGICAL-c260t-a2bfab77dd314d2065aa34d2d83230036e238383190077cf480d49d5dc47dd0e3</originalsourceid><addsrcrecordid>eNotkM1LAzEQxYMoWKtH7wHPWycfm909SlEr1A9EzyFNsm1Ku1mTrFL_erNU5jCPYd6b4YfQNYFZKYDdvjy_zygQOgMAfoImRHBecMbL06xLEEUjajhHFzFuAUpOKZmg37fg152PyWn8rXaDxb7F-4PXKhindri3oR2i8x2O2nXJrYPqNwfc-oB7lZztUsRxiL3VyZrRqzqDs3PMzIMflzZY--A7FQ5YhWRzMy5aFe0lOmvVLtqr_z5Fnw_3H_NFsXx9fJrfLQtNBaRC0VWrVlVlDCPcUBClUiwLUzPKAJiwlNW5SANQVbrlNRjemNJonj1g2RTdHHP74L8GG5Pc-iF0-aSkXGQMgrAmbxXHLR18jMG2sg9un7-WBOSIV2a8csQrR7zsD5dyb30</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2464226139</pqid></control><display><type>article</type><title>Prognostic value of myocardial perfusion scintigraphy for patients suspected of and diagnosed with coronary artery disease</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Zorga, Piotr ; Birkenfeld, Bożena ; Listewnik, Maria Henryka ; Piwowarska-Bilska, Hanna</creator><creatorcontrib>Zorga, Piotr ; Birkenfeld, Bożena ; Listewnik, Maria Henryka ; Piwowarska-Bilska, Hanna</creatorcontrib><description>BACKGROUND: The prognostic value of myocardial perfusionscintigraphy (MPS) continues to attract interest and provoke discussions.This study was an attempt to investigate the methods.Objective: Determination of the prognostic value of MPSfor patients suspected of and diagnosed with coronary arterydisease (CAD).MATERIAL AND METHODS: The study group included 215patients, 134 males and 81 females, aged 21–66, mean age48. Tc-99m-MIBI myocardial perfusion scintigraphy was performedand information concerning the diagnosis, aim of theexamination, past coronary episodes, clinical condition, durationand type of complaints, concomitant diseases, test results,revascularisation procedures and pharmacological treatmentwas gathered. Further history of the patients was monitoredthroughout the observation period of 52 months on average.The patients were divided into the following two groups: GroupI — suspected coronary artery disease: 124 patients aged 21–65,59 males and 65 females; Group II — diagnosed coronary arterydisease: 91 patients aged 31–66, 75 males and 16 femalesdiagnosed with CAD, including 39 s/p myocardial infarct, 31s/p infarct and revascularisation, 21 s/p revascularisation. Theprobability of CAD was calculated using the Diamond methodfor the patients suspected of CAD. The obtained results wereexamined in a statistical analysis.RESULTS: Normal MPS results were obtained for 94/124 patientssuspected of CAD, 15/91 patients diagnosed with CAD,64/81 females and 45/134 males. In Group I, apart from pathologicalMPS results, reversible ischemia was determined in asmany as 27/30 patients, and only 17/91 patients in Group II. Nopatients with normal MPS results suffered major cardiac events,only one of them underwent revascularisation. Major cardiacevents occurred in the case of patients with pathological MPSresults: Group I — 2 myocardial infarcts and 2 cardiac deaths,Group II — 3 infarcts and 10 cardiac deaths. Minor cardiacevents, apart from one case, were also only observed in thecase of patients with pathological MPS results: Group I — 10revascularisations and one case of unstable CAD, Group II— 12 revascularisations and 7 cases of unstable CAD. Patientswith normal MPS results and stenosis in coronary angioraphysuffered no cardiac events. Cardiac events occur mostly in thegroup with a medium and high risk of CAD and in the case ofpatients diagnosed with CAD.CONCLUSIONS: 1. Normal MPS results for patients suspectedof or diagnosed with CAD: s/p infarct and/or CABG prognosticatea mild course of the disease, without or with a minimalnumber of cardiac events, also in a longer observation period.2. Pathological MPS results clearly imply a greater risk of cardiacevents, and the number of events increases with the greaterprobability of CAD and with the patient’s age. 3. Normal MPSresults, even with significant stenosis in coronary angiography,prognosticate a low risk of cardiac events.</description><identifier>ISSN: 1506-9680</identifier><identifier>EISSN: 1644-4345</identifier><identifier>DOI: 10.5603/NMR.2012.0004</identifier><language>eng</language><publisher>Gdansk: Wydawnictwo Via Medica</publisher><subject>Cardiovascular disease ; Coronary vessels ; Scintigraphy ; Stents</subject><ispartof>Nuclear medicine review. Central &amp; Eastern Europe, 2012-01, Vol.15 (1), p.14-21</ispartof><rights>2012. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids></links><search><creatorcontrib>Zorga, Piotr</creatorcontrib><creatorcontrib>Birkenfeld, Bożena</creatorcontrib><creatorcontrib>Listewnik, Maria Henryka</creatorcontrib><creatorcontrib>Piwowarska-Bilska, Hanna</creatorcontrib><title>Prognostic value of myocardial perfusion scintigraphy for patients suspected of and diagnosed with coronary artery disease</title><title>Nuclear medicine review. Central &amp; Eastern Europe</title><description>BACKGROUND: The prognostic value of myocardial perfusionscintigraphy (MPS) continues to attract interest and provoke discussions.This study was an attempt to investigate the methods.Objective: Determination of the prognostic value of MPSfor patients suspected of and diagnosed with coronary arterydisease (CAD).MATERIAL AND METHODS: The study group included 215patients, 134 males and 81 females, aged 21–66, mean age48. Tc-99m-MIBI myocardial perfusion scintigraphy was performedand information concerning the diagnosis, aim of theexamination, past coronary episodes, clinical condition, durationand type of complaints, concomitant diseases, test results,revascularisation procedures and pharmacological treatmentwas gathered. Further history of the patients was monitoredthroughout the observation period of 52 months on average.The patients were divided into the following two groups: GroupI — suspected coronary artery disease: 124 patients aged 21–65,59 males and 65 females; Group II — diagnosed coronary arterydisease: 91 patients aged 31–66, 75 males and 16 femalesdiagnosed with CAD, including 39 s/p myocardial infarct, 31s/p infarct and revascularisation, 21 s/p revascularisation. Theprobability of CAD was calculated using the Diamond methodfor the patients suspected of CAD. The obtained results wereexamined in a statistical analysis.RESULTS: Normal MPS results were obtained for 94/124 patientssuspected of CAD, 15/91 patients diagnosed with CAD,64/81 females and 45/134 males. In Group I, apart from pathologicalMPS results, reversible ischemia was determined in asmany as 27/30 patients, and only 17/91 patients in Group II. Nopatients with normal MPS results suffered major cardiac events,only one of them underwent revascularisation. Major cardiacevents occurred in the case of patients with pathological MPSresults: Group I — 2 myocardial infarcts and 2 cardiac deaths,Group II — 3 infarcts and 10 cardiac deaths. Minor cardiacevents, apart from one case, were also only observed in thecase of patients with pathological MPS results: Group I — 10revascularisations and one case of unstable CAD, Group II— 12 revascularisations and 7 cases of unstable CAD. Patientswith normal MPS results and stenosis in coronary angioraphysuffered no cardiac events. Cardiac events occur mostly in thegroup with a medium and high risk of CAD and in the case ofpatients diagnosed with CAD.CONCLUSIONS: 1. Normal MPS results for patients suspectedof or diagnosed with CAD: s/p infarct and/or CABG prognosticatea mild course of the disease, without or with a minimalnumber of cardiac events, also in a longer observation period.2. Pathological MPS results clearly imply a greater risk of cardiacevents, and the number of events increases with the greaterprobability of CAD and with the patient’s age. 3. Normal MPSresults, even with significant stenosis in coronary angiography,prognosticate a low risk of cardiac events.</description><subject>Cardiovascular disease</subject><subject>Coronary vessels</subject><subject>Scintigraphy</subject><subject>Stents</subject><issn>1506-9680</issn><issn>1644-4345</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNotkM1LAzEQxYMoWKtH7wHPWycfm909SlEr1A9EzyFNsm1Ku1mTrFL_erNU5jCPYd6b4YfQNYFZKYDdvjy_zygQOgMAfoImRHBecMbL06xLEEUjajhHFzFuAUpOKZmg37fg152PyWn8rXaDxb7F-4PXKhindri3oR2i8x2O2nXJrYPqNwfc-oB7lZztUsRxiL3VyZrRqzqDs3PMzIMflzZY--A7FQ5YhWRzMy5aFe0lOmvVLtqr_z5Fnw_3H_NFsXx9fJrfLQtNBaRC0VWrVlVlDCPcUBClUiwLUzPKAJiwlNW5SANQVbrlNRjemNJonj1g2RTdHHP74L8GG5Pc-iF0-aSkXGQMgrAmbxXHLR18jMG2sg9un7-WBOSIV2a8csQrR7zsD5dyb30</recordid><startdate>20120101</startdate><enddate>20120101</enddate><creator>Zorga, Piotr</creator><creator>Birkenfeld, Bożena</creator><creator>Listewnik, Maria Henryka</creator><creator>Piwowarska-Bilska, Hanna</creator><general>Wydawnictwo Via Medica</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20120101</creationdate><title>Prognostic value of myocardial perfusion scintigraphy for patients suspected of and diagnosed with coronary artery disease</title><author>Zorga, Piotr ; Birkenfeld, Bożena ; Listewnik, Maria Henryka ; Piwowarska-Bilska, Hanna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c260t-a2bfab77dd314d2065aa34d2d83230036e238383190077cf480d49d5dc47dd0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Cardiovascular disease</topic><topic>Coronary vessels</topic><topic>Scintigraphy</topic><topic>Stents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zorga, Piotr</creatorcontrib><creatorcontrib>Birkenfeld, Bożena</creatorcontrib><creatorcontrib>Listewnik, Maria Henryka</creatorcontrib><creatorcontrib>Piwowarska-Bilska, Hanna</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Nuclear medicine review. Central &amp; Eastern Europe</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zorga, Piotr</au><au>Birkenfeld, Bożena</au><au>Listewnik, Maria Henryka</au><au>Piwowarska-Bilska, Hanna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic value of myocardial perfusion scintigraphy for patients suspected of and diagnosed with coronary artery disease</atitle><jtitle>Nuclear medicine review. Central &amp; Eastern Europe</jtitle><date>2012-01-01</date><risdate>2012</risdate><volume>15</volume><issue>1</issue><spage>14</spage><epage>21</epage><pages>14-21</pages><issn>1506-9680</issn><eissn>1644-4345</eissn><abstract>BACKGROUND: The prognostic value of myocardial perfusionscintigraphy (MPS) continues to attract interest and provoke discussions.This study was an attempt to investigate the methods.Objective: Determination of the prognostic value of MPSfor patients suspected of and diagnosed with coronary arterydisease (CAD).MATERIAL AND METHODS: The study group included 215patients, 134 males and 81 females, aged 21–66, mean age48. Tc-99m-MIBI myocardial perfusion scintigraphy was performedand information concerning the diagnosis, aim of theexamination, past coronary episodes, clinical condition, durationand type of complaints, concomitant diseases, test results,revascularisation procedures and pharmacological treatmentwas gathered. Further history of the patients was monitoredthroughout the observation period of 52 months on average.The patients were divided into the following two groups: GroupI — suspected coronary artery disease: 124 patients aged 21–65,59 males and 65 females; Group II — diagnosed coronary arterydisease: 91 patients aged 31–66, 75 males and 16 femalesdiagnosed with CAD, including 39 s/p myocardial infarct, 31s/p infarct and revascularisation, 21 s/p revascularisation. Theprobability of CAD was calculated using the Diamond methodfor the patients suspected of CAD. The obtained results wereexamined in a statistical analysis.RESULTS: Normal MPS results were obtained for 94/124 patientssuspected of CAD, 15/91 patients diagnosed with CAD,64/81 females and 45/134 males. In Group I, apart from pathologicalMPS results, reversible ischemia was determined in asmany as 27/30 patients, and only 17/91 patients in Group II. Nopatients with normal MPS results suffered major cardiac events,only one of them underwent revascularisation. Major cardiacevents occurred in the case of patients with pathological MPSresults: Group I — 2 myocardial infarcts and 2 cardiac deaths,Group II — 3 infarcts and 10 cardiac deaths. Minor cardiacevents, apart from one case, were also only observed in thecase of patients with pathological MPS results: Group I — 10revascularisations and one case of unstable CAD, Group II— 12 revascularisations and 7 cases of unstable CAD. Patientswith normal MPS results and stenosis in coronary angioraphysuffered no cardiac events. Cardiac events occur mostly in thegroup with a medium and high risk of CAD and in the case ofpatients diagnosed with CAD.CONCLUSIONS: 1. Normal MPS results for patients suspectedof or diagnosed with CAD: s/p infarct and/or CABG prognosticatea mild course of the disease, without or with a minimalnumber of cardiac events, also in a longer observation period.2. Pathological MPS results clearly imply a greater risk of cardiacevents, and the number of events increases with the greaterprobability of CAD and with the patient’s age. 3. Normal MPSresults, even with significant stenosis in coronary angiography,prognosticate a low risk of cardiac events.</abstract><cop>Gdansk</cop><pub>Wydawnictwo Via Medica</pub><doi>10.5603/NMR.2012.0004</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1506-9680
ispartof Nuclear medicine review. Central & Eastern Europe, 2012-01, Vol.15 (1), p.14-21
issn 1506-9680
1644-4345
language eng
recordid cdi_proquest_journals_2464226139
source DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals
subjects Cardiovascular disease
Coronary vessels
Scintigraphy
Stents
title Prognostic value of myocardial perfusion scintigraphy for patients suspected of and diagnosed with coronary artery disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T22%3A38%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20value%20of%20myocardial%20perfusion%20scintigraphy%20for%20patients%20suspected%20of%20and%20diagnosed%20with%20coronary%20artery%20disease&rft.jtitle=Nuclear%20medicine%20review.%20Central%20&%20Eastern%20Europe&rft.au=Zorga,%20Piotr&rft.date=2012-01-01&rft.volume=15&rft.issue=1&rft.spage=14&rft.epage=21&rft.pages=14-21&rft.issn=1506-9680&rft.eissn=1644-4345&rft_id=info:doi/10.5603/NMR.2012.0004&rft_dat=%3Cproquest_cross%3E2464226139%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2464226139&rft_id=info:pmid/&rfr_iscdi=true